Ellevest, Inc. Edwards Lifesciences Corp Transaction History

Ellevest, Inc.

$608 Million
Q2 2025

A detailed history of Ellevest, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ellevest, Inc. holds 7,372 shares of EW stock, worth $615,414. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,372

Previous 8,401 12.25%

Holding current value

$615,414

Previous $608,000 5.26%

% of portfolio

0.09%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$67.07 - $78.22 $69,015 - $80,488	-1,029 Reduced 12.25%	7,372 $576,000
Q1 2025 May 14, 2025	BUY	$67.95 - $76.19 $59,320 - $66,513	873 Added 11.6%	8,401 $608,000
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $145,731 - $171,427	-2,258 Reduced 23.07%	7,528 $557,000
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $192,054 - $301,690	3,217 Added 48.97%	9,786 $645,000
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $25,037 - $28,010	297 Added 4.74%	6,569 $606,000
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $11,098 - $14,620	153 Added 2.5%	6,272 $599,000
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $29,991 - $37,791	-486 Reduced 7.36%	6,119 $466,000
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $29,513 - $39,779	426 Added 6.89%	6,605 $457,000
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $12,374 - $14,338	152 Added 2.52%	6,179 $582,000
Q1 2023 May 04, 2023	SELL	$74.26 - $84.51 $111,909 - $127,356	-1,507 Reduced 20.0%	6,027 $498,000
Q4 2022 Feb 03, 2023	SELL	$68.3 - $87.44 $67,821 - $86,827	-993 Reduced 11.65%	7,534 $562,000
Q3 2022 Nov 02, 2022	SELL	$82.37 - $107.29 $68,119 - $88,728	-827 Reduced 8.84%	8,527 $705,000
Q2 2022 Jul 18, 2022	SELL	$86.5 - $128.27 $15,829 - $23,473	-183 Reduced 1.92%	9,354 $889,000
Q1 2022 Apr 19, 2022	BUY	$101.96 - $128.34 $62,195 - $78,287	610 Added 6.83%	9,537 $1.12 Million
Q4 2021 Jan 24, 2022	BUY	$106.37 - $130.68 $15,742 - $19,340	148 Added 1.69%	8,927 $1.16 Million
Q3 2021 Oct 19, 2021	BUY	$102.91 - $122.75 $41,987 - $50,082	408 Added 4.87%	8,779 $994,000
Q2 2021 Jul 13, 2021	BUY	$83.84 - $104.76 $701,824 - $876,945	8,371 New	8,371 $867,000
Q1 2021 May 03, 2021	BUY	$78.68 - $90.67 $621,650 - $716,383	7,901 New	7,901 $661,000
Q4 2020 Feb 04, 2021	SELL	$71.69 - $91.23 $715,752 - $910,840	-9,984 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$67.19 - $87.44 $46,697 - $60,770	695 Added 7.48%	9,984 $797,000
Q2 2020 Jul 06, 2020	BUY	$57.54 - $76.95 $363,537 - $486,170	6,318 Added 212.66%	9,289 $642,000
Q1 2020 Apr 13, 2020	BUY	$52.41 - $81.0 $153,246 - $236,844	2,924 Added 6221.28%	2,971 $560,000
Q4 2019 Feb 05, 2020	BUY	$71.7 - $82.09 $2,437 - $2,791	34 Added 261.54%	47 $11,000
Q3 2019 Oct 08, 2019	BUY	$61.55 - $75.43 $246 - $301	4 Added 44.44%	13 $3,000
Q2 2019 Aug 20, 2019	SELL	$55.74 - $64.41 $501 - $579	-9 Reduced 50.0%	9 $2,000
Q4 2018 Jan 25, 2019	BUY	$46.41 - $56.94 $835 - $1,024	18 New	18 $3,000

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

487M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $51.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account